期刊文献+

肺腺癌微淋巴管的分布及其临床意义

Distribution of microlymphatic vessels in lung adenocarcinoma and its clinical significance
暂未订购
导出
摘要 目的研究肺腺癌组织中血管内皮生长因子C(VEGF-C)、血管内皮生长因子D(VEGF-D)蛋白表达与微淋巴管密度(MLVD)及淋巴结转移之间的关系,探讨癌周淋巴管生成的机制。方法采用逆转录聚合酶链法(RT-PCR),检测VEGF-C、VEGF-D在48例肺腺癌新鲜组织中的表达;采用免疫组织化学法检测肺腺癌组织周边和内部VEGF-C、VEGF-D和MLVD蛋白的表达。结果VEGF-C和VEGF-D mRNA在肺腺癌组织中高表达,在正常肺组织低表达(P<0.01);VEGF-C、VEGF-D蛋白阳性率分别为70.8%(34/48)和58.3%(28/48),其中肿瘤周边部位的表达显著高于肿瘤中心部位,差异有统计学意义;在VEGF-C、VEGF-D蛋白阳性组,MLVD显著高于阴性组(P<0.01),淋巴结转移发生率增加(P=0.042,P=0.012)。结论VEGF-C和VEGF-D的表达可诱导肺腺癌癌周淋巴管的生成,促进肿瘤的经淋巴道转移。 Objective To investigate the relationship among vascular endothelial growth factor -C, (VEGF-C), VEGF-D, microlymphafic vessel density (MLVD) and lymph node metastasis in lung adenoearcinoma, and to explore the mechanism of cancereus peripheral tissue lymphatic vessels. Methods The expressions of VEGF-C and VEGF-D mRNA were determined by the semi-quantitative reverse transcriptase-polymerase chain reaction method and the expressions of VEGF-C, VEGF-D and MLVD were determined in the center of the tumors and peripheral tissues by means of irranunohistoehemistry in 48 cases of lung adenocarcinoma. Results Expressions of VEGF-C and VEGF-D mRNA were higher in lung cancer than in normal lung tissues, positive ratio of VEGF-C and VEGF-D was 70.8% (34/48) and 58.3(28/48). The expressions of VEGF-C and VEGF-D in cancerous peripheral tissues were significantly higher than those in the center of the tumors. The MLVD and positive lymph node metastasis in the positive VEGF-C or VEGF-D group were higher than those in the negative group. Conclusion The expression of VEGF-C and VEGF-D can induce lymphangiogenesis of lung adenocarcinoma and lymph metastasis.
出处 《山东大学学报(医学版)》 CAS 北大核心 2008年第6期616-619,共4页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金资助项目(2005ZRB14159)
关键词 肺肿瘤 血管生成因子 淋巴结 Lung neoplasms Angiegenesis factor Lymph nodes
  • 相关文献

参考文献9

  • 1Nakamura Y, Yasuoka H, Tsujimoto M, et al. Fit4 positive vessel density correlates with vascular endothelial growth factord expression, nodal states, and prognosis in breast cancer[J]. Clin Cancer Res, 2003, 9 ( 14 ) : 5313-5317.
  • 2Makinen T, Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3[J]. Nat Med, 2001, 7 (2) : 199-205.
  • 3Veikkola T, Lotta Jussila, Makinen T, et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice[J]. EMOB J, 2001, 20 (6) : 1223-1231.
  • 4曹桂明,杨梅.VEGF-C和VEGFR-3对乳腺癌淋巴管生成和淋巴结转移的影响[J].中国肿瘤临床,2006,33(6):310-313. 被引量:16
  • 5Hung C J, Ginzinger D G, Zarnegar R, et al. Expression of vascular endothelial growth factor C in benign and mahgnant thyroid tumors [ J ]. J Clin Endocrinol Meta, 2003, 88 (8) : 3694-3699.
  • 6Ishikawa M, Kitayama J, Kazama S, et al. Experssion of vascular endothelial growth factor(VEGF-C) in preoperative biosy specimens and metastatic foci of regional lymph nodes in submucosal gastric carcinoma[ J]. World J Surg Oncol, 2005, 3 (1):2.
  • 7Onogawa S, Kitadai Y, Tanaka S, et al. Expression of VEGF- C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma [J]. Cancer Sci, 2004, 95(1):32-39.
  • 8Beasley N J, Prevo R, Banerji S, et al. Entratumoral lymphangiogenesis and lymh node metastasia in head and neck cancer[J]. Cancer Res, 2002, 62(17):1315-1320.
  • 9Padera T P, Kadambi A, Di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics [J]. Science, 2002, 296(5574) : 1883-1886.

二级参考文献10

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部